Clinical, cognitive, and mean diffusivity measures for the HIV patients
| Patient No. | Clival | Calvarial | MSK | CD4 | Viral Load (log10) | Therapy |
|---|---|---|---|---|---|---|
| 1 | 0.000691 | 0.000854 | 2 | 174 | 3.914 | 3-TC, Kaletra,* Ziagen |
| 2 | 0.001017 | 0.000784 | 1 | 220 | 1.903 | 3-TC, Indinavir,* Nevirapine |
| 3 | 0.000907 | 0.000866 | 1 | 108 | 2.623 | ddl, Efavirenz, DMP266, Viread |
| 4 | 0.000771 | 0.001021 | 1 | 397 | 1.903 | Efavirenz, DMP266, Viread, Ziagen, Kaletra* |
| 5 | 0.000873 | 0.000851 | .5 | 81 | 3.204 | Kaletra,* Combivir |
| 6 | 0.000757 | 0.000770 | .5 | 373 | 1.903 | 3-TC, d4T, Viracept* |
| 7 | 0.000427 | 0.000729 | .5 | 427 | 1.903 | Ziagen, Kaletra* |
| 8 | 0.000822 | 0.000890 | .5 | 310 | 1.903 | Norvir,* Saquinavir,* Ziagen |
| 9 | 0.000941 | 0.000740 | .5 | 24 | 5.49 | None (drug holiday) |
| 10 | 0.000612 | 0.000844 | 1 | 122 | 4.699 | 3-TC, Norvir,* Amprenavir, Ziagen, Kaletra,* Tenofovir |
| 11 | 0.000632 | 0.001137 | 0.5 | 240 | 3.322 | 3-TC, AZT, ddl, Ziagen, Kaletra,* T20, Tenofovir |
Note:—MSK indicates Memorial Sloan Kettering rating scale.
* Protease inhibitor.